File(s) not publicly available
A Review of Current Treatment Options for Glioblastoma Multiforme
journal contribution
posted on 2023-05-17, 11:19 authored by Nicols, LTreatment options for most patients diagnosed with a Glioblastoma Multiforme consist of surgery, radiotherapy and chemotherapy. Despite recent advances treatments remains palliative and not curative. The life expectancy for patients is still dismal, and in this context, the objective should be towards improving not only quantity but also quality of life. The following paper is a critical review of the literature pertaining to the treatment of Glioblastoma Multiforme, focusing on the use of the two most available and utilised chemotherapy regimes. Specifically, the oral alkylating agent Temozolomide and surgically implanted polymer wafers impregnated with Carmustine (commonly known under the name of ‘Gliadel’).
History
Publication title
Australasian Journal of NeuroscienceVolume
21Pagination
19-25ISSN
1032-335XDepartment/School
School of NursingPublisher
Australasian Neuroscience Nurses AssociationPlace of publication
VictoriaRepository Status
- Restricted